Rare diseases
Investigational molecules
Locations
Back to Italy21 clinical trials in Legnago, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on non-small cell lung cancer treatments, particularly evaluating combination therapies including immunotherapy approaches and targeted treatments.
Studies are examining novel treatment combinations with pembrolizumab and other immunotherapy agents for improved patient outcomes.
Comprehensive research into early breast cancer treatments, with particular focus on hormone receptor-positive and HER2-negative disease variants.
Trials are evaluating new therapeutic approaches including adjuvant treatments and novel drug combinations.
Advanced studies examining treatments for recurrent ovarian cancer and related conditions, with emphasis on maintenance therapy approaches.
Investigations focus on improving treatment outcomes through targeted therapies and personalized approaches.
Studies addressing advanced colorectal cancer treatment strategies, including targeted therapies and novel drug combinations.
Research focuses on personalized treatment approaches based on genetic markers and disease staging.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
